5-Amino-1MQ (25mg) is a small-molecule NNMT inhibitor designed to increase NAD+ availability, enhance energy expenditure, and reduce fat cell size.
This compound has been studied for its ability to improve metabolic function by shifting the body toward greater energy utilization and promoting fat oxidation.
Research suggests 5-Amino-1MQ may support better insulin sensitivity and glucose regulation, making it relevant for metabolic and obesity-related studies.
By modulating NAD+ pathways, 5-Amino-1MQ also supports mitochondrial performance, cellular energy, and longevity-related mechanisms.
Formulated for researchers investigating fat loss, metabolic health, and cellular energy, 5-Amino-1MQ (25mg) Tablets x60 offer a unique pathway into advanced metabolic science.
